Analyze Your Search

Hints:

  • Action links for each search result record
    • Bookmark: Allows you to Bookmark the page for easy future retrieval 
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • More Info: Shows full summary of content record
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Follow" button to the right of the search box. 
Hepatitis
  Follow Topic   Edit Search
Your search returned 87 results
from the time period: last 30 days.
Sort by Relevance / Date Group By Journal / No Grouping
The Journal of infectious diseases
DescriptorName: Hepatitis B. DescriptorName: Hepatitis B Antibodies... AbstractText: Hepatitis B vaccine is an effective measure to prevent hepatitis B virus infection ... Whether chronic hepatitis C virus (HCV) infection decreases humoral and cell-mediated immunity responses to hepatitis B vaccination is still controversial AbstractText: Patients with chronic HCV ... provided preliminary evidence of the good immunogenicity and safety of hepatitis B vaccination among patients in China with chronic hepatitis C who are not in treatment AbstractText: NCT 02898922 Keyword ...
Infectious Diseases (17), Vaccines (6)
Hepatitis B (12), Chronic Hepatitis C (4), Infections (3), more mentions
The New England journal of medicine 
CitationSubset: AIM. CitationSubset: IM. DescriptorName: Delivery of Health Care. DescriptorName: Epidemics. DescriptorName: Health Care Costs. DescriptorName: Healthcare Disparities. DescriptorName: Hepatitis C. DescriptorName: Humans. DescriptorName: Incidence. DescriptorName: Indians, North American. DescriptorName: United States. DescriptorName: United States Department of Veterans Affairs. DescriptorName: United States Indian Health Service. DescriptorName: Veterans.
Infectious Diseases (1)
Hepatitis C (1), more mentions
The American journal of gastroenterology
Abstract: Interferon-based therapy for chronic hepatitis C in elderly patients, who are at greatest risk for advanced disease, resulted in low sustained virologic response rates, poor tolerability, a significant frequency of adverse events leading to treatment discontinuation, and the occasional precipitation of hepatic decompensation. In contrast, in the era of direct-acting antiviral therapy, age is no longer a ...
Infectious Diseases (2), Immune System Diseases (2)
Chronic Hepatitis C (2), Cirrhosis (1), more mentions
The American journal of gastroenterology
AbstractText: Data on clinical manifestations and outcome of hepatic sarcoidosis are scarce... study aimed to use a population-based cohort of patients with incident sarcoidosis to better describe the characteristics of hepatic sarcoidosis AbstractText: A cohort of incident cases of sarcoidosis in Olmsted County, MN, USA, from 1976 to 2013 was ...
Sarcoidosis (9), Cirrhosis (3), Granuloma (2), more mentions
Alimentary pharmacology & therapeutics
AbstractText: Chronic hepatitis C virus (HCV) infection is the leading cause of cirrhosis and hepatocellular carcinoma (HCC) in the ... United States (US) and an emerging cause in China AbstractText: To compare the clinical characteristics of hepatitis C patients in the US and China, and factors influencing disease stage AbstractText: Prospective study of ...
Infectious Diseases (3), Anti-Obesity and Weight Loss (3), Endocrine Disorders (2)
Cirrhosis (3), Infections (3), Liver Diseases (2), more mentions
Radiology
Abstract: Purpose To determine the linearity, bias, and precision of hepatic proton density fat fraction (PDFF) measurements by using magnetic resonance (MR) imaging across ... systematic literature search identified studies that evaluated the linearity and/or bias of hepatic PDFF measurements by using MR imaging (hereafter, MR imaging-PDFF) against PDFF measurements ...
Journal of hepatology
Such experiments led to a clear distinction between hepatitis A ('infectious hepatitis') and hepatitis B ('homologous serum jaundice') and recognition of the lack of cross immunity between these two forms of transmissible hepatitis as early as 19453 ... in in-depth overview of HAV and the acute inflammatory hepatic infection it causes in humans, including recently recognized aspects of ...
Infectious Diseases (7), Vaccines (1)
Hepatitis A (4), Jaundice (3), Infections (2), more mentions
Journal of hepatology
AbstractText: The Hepatitis B Virus (HBV) is carried in many non-liver cell types but does not actively replicate in them. We investigated the possibility that these cells possess HBVCP transcription inhibitory mechanisms specifically absent in liver cells, which together with other liver-specific mechanisms such as NTCP-mediated entry, enable liver cells to effectively produce HBV AbstractText: Liver and ...
Infectious Diseases (2)
Hepatitis B (2), Infections (1), more mentions
Digestive diseases and sciences
BACKGROUND: Suppressive activity of recurrence by interferon-free direct-acting antivirals (DAA) is not elucidated after curative treatment of hepatocellular carcinoma (HCC). PATIENTS AND METHODS: A total of 177 patients received DAA after curative manners of HCC: 89 patients underwent DAA therapy after initial HCC treatment, and the other 88 patients after repeated therapy of 2-10 times. Among a cohort of HCC patients with surgery and radiofrequency ablation, 89 patients were chosen adjusting age, gender, and Barcelona Clinic Liver Cancer (BCLC) staging with 89 patients with initial HCC therapy. RESULTS: HCC recurrence rates at the end of first and second year were 18.1 and 22.1% in patients with once of HCC therapy, 28.2 and 41.6% in those with 2-3 times of therapy, and 60.2 and 74.5% in those with 4 or more times of therapy, respectively (P < 0.0001). Recurrence rates were compared between 89 patients with DAA therapy after initial HCC therapy and 89 age-, gender-, and BCLC staging-matched patients without antiviral therapy after initial HCC therapy. HCC recurrence rates at first and second year were 18.1 and 25.0% in patients with DAA therapy and 21.8 and 46.5% in those without DAA therapy, respectively (P = 0.003). Multivariate analysis showed DAA therapy significantly decreased recurrence rate with a hazard ratio of 0.353 (confidence interval: 0.191-0.651) after adjustment with covariates of tumor multiplicity, alpha-fetoprotein value, and prothrombin time. CONCLUSIONS: DAA therapy significantly decreased recurrence rate when it was performed after initial HCC therapy.
Infectious Diseases (1), Oncology (1), Immune System Diseases (1)
Hepatocellular Carcinoma (3), Neoplasms (2), Liver Neoplasms (1), more mentions
Transplantation
Meta-analyses were performed to evaluate the incidence of all hepatic artery complications, hepatic artery thrombosis and biliary tract complications, using binary random-effect ... Postoperative hepatic artery complications consisted of hepatic artery thrombosis, stenosis and (pseudo)-aneurysms ... No significant association between neoadjuvant TACE and hepatic artery thrombosis alone or biliary tract complications was found AbstractText ...
Oncology (1)
Thrombosis (3), Pathologic Constriction (1), Liver Neoplasms (1), more mentions
Clinical journal of the American Society of Nephrology : CJASN 
AbstractText: Hepatitis C virus infection is common in patients with CKD and ... Sofosbuvir is a potent direct-acting antiviral therapy against hepatitis C virus; however, there are concerns about its safety in ... 2) at baseline (stage 3 CKD), regression models showed that hepatitis C cure was associated with a 9.3 (95% confidence interval ...
Infectious Diseases (6), Endocrine Disorders (3), Immune System Diseases (3)
Hepatitis C (6), Diabetes Mellitus (3), Cirrhosis (2), more mentions
Clinical journal of the American Society of Nephrology : CJASN 
Keyword: Disease Management. Keyword: Hepacivirus. Keyword: Hepatitis C. Keyword: Humans. Keyword: Renal Insufficiency, Chronic.
Infectious Diseases (2)
Hepatitis C (2), Renal Insufficiency (1), more mentions
Transplantation
AbstractText: Hepatitis B immune globulin (HBIG) has been an integral component of prophylaxis against hepatitis B virus (HBV) recurrence in liver transplantation (LT) recipients, but ... 100 IU/mL pre-LT AbstractText: A total of 42 hepatitis B surface antigen (HBsAg) positive, human immunodeficiency virus and hepatitis D virus-negative patients with pretransplant HBV DNA undetectable to ...
Infectious Diseases (5), Immune System Diseases (3)
Hepatitis B (4), Viremia (3), Hepatitis D (1), more mentions
Scandinavian journal of gastroenterology
... This study aims to investigate the kinetics of serum HBsAg levels in chronic hepatitis B patients with long-term nucleos(t)ide analogs (NAs) therapy AbstractText: This ... a predictor of serum HBsAg <1000 IU/mL at year 8 Keyword: Chronic hepatitis B. Keyword: antiviral therapy. Keyword: hepatitis B surface antigen quantification.
Infectious Diseases (4), Immune System Diseases (3)
Chronic Hepatitis B (3), Hepatitis B (1), more mentions
Alimentary pharmacology & therapeutics
AbstractText: In the era of highly effective direct-acting antivirals (DAAs) for treatment of patients with chronic hepatitis C virus (HCV) infection, ribavirin (RBV) is still considered beneficial in certain patients AbstractText: To assess the association between RBV steady-state plasma levels and sustained virological response (SVR) AbstractText: Consecutive HCV ...
Infectious Diseases (2)
Cirrhosis (1), Chronic Hepatitis C (1), Infections (1), more mentions
Scandinavian journal of gastroenterology
... non-infected patients indicating lack of ammonia decline in infected patients AbstractText: Cerebral edema, elevated ammonia on day 3, and higher MELD score predict the development of infection in ALF. Ammonia persists at high levels in infected patients, and elevated ammonia on day 3 is associated with complications and death Keyword: Acute hepatitis E. Keyword: SIRS. Keyword: anti-tubercular drugs.
Infectious Diseases (2)
Infections (11), Cerebral Edema (2), Acute Liver Failure (2), more mentions
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
AbstractText: & Aims: Hepatocellular (HCC) surveillance guidelines for patients with chronic hepatitis B virus (HBV) infection are based on race- and age-specific estimates of HCC risk, derived from studies conducted in areas in which HBV is endemic AbstractText: We conducted a retrospective cohort study using the national ... Keyword: viral hepatitis.
Infectious Diseases (3), Oncology (1)
Cirrhosis (5), Infections (4), Hepatocellular Carcinoma (2), more mentions
Digestive diseases and sciences
AbstractText: The clinical course of chronic hepatitis B (CHB) patients with partial virologic response (PVR) during tenofovir disoproxil fumarate (TDF) therapy remains unclear AbstractText: We retrospectively investigated the long ... This suggests that adjustment of TDF therapy in patients with PVR is unnecessary Keyword: Chronic hepatitis B. Keyword: Partial virologic response.
Infectious Diseases (3)
Chronic Hepatitis B (3), more mentions
Digestive diseases and sciences
AbstractText: Beyond available guidelines, therapy of autoimmune hepatitis (AIH) shows wide variation among physicians... In patients with severe interface hepatitis, the complete response rates were significantly higher in group II than in group I after 3 (63.6 vs. 23.1%, p = 0.02) and 6 months ... Keyword: Autoimmune hepatitis... Keyword: Interface hepatitis.
Infectious Diseases (5), Immune System Diseases (3)
Autoimmune Hepatitis (3), Hepatitis (2), more mentions
Hepatology (Baltimore, Md.)
AbstractText: We aimed to assess the risk of chronic kidney disease (CKD) in chronic hepatitis C virus (HCV) infected patients and the incidence reduction of CKD after receipt of HCV treatment. We also evaluated the risk of membranoproliferative glomerulonephritis (MPGN) and cryoglobulinemia in chronic HCV patients. A retrospective cohort analysis of the Truven Health MarketScan Database (2008-2015) in the ...
Kidney Disease (2), Infectious Diseases (2), Immune System Diseases (1)
Membranoproliferative Glomerulonephritis (4), Cryoglobulinemia (3), Infections (3), more mentions
1 2 3 4 5  | Next Page»